SZSE Ticker: 300003

Lepu Medical Technology (Beijing) Co., Ltd.

乐普（北京）医疗器械股份有限公司

乐普医疗

LEPU MEDICAL

Listing Date: 2009-10-30

Board: GEM

Industry Classification: Manufacturing

The financing balance of GEM companies decreased by 705 million yuan during the three consecutive declines_Oriental Fortune Net

The financing balance of GEM companies decreased by 705 million yuan during the three consecutive declines_Oriental Fortune Net

Zhongsheng Ruichuang's 3CL protease inhibitor clinical trial application was accepted by NMPA, and domestic new crown drugs accelerated

Lepu Medical (300003): Announcement on Precautions for Participating in the 2021 Annual General Meeting during the Epidemic Prevention and Control Period-

Lepu Medical (300003): Informative Announcement on Precautions for Participating in the 2021 Annual General Meeting during the Epidemic Prevention and Control Period- CFi.CN Zhongcai Network

The industry is booming, and the pharmaceutical sector has become the "most handsome" with long-term investment value

The industry is booming, and the pharmaceutical sector has become the "most handsome" with long-term investment value_ Oriental Fortune Net

The price of centralized procurement has fallen below 4 yuan: is the new crown antigen detection reagent still a good track? Jiu'an Medical_Sina Finance_Sina.com

Weekend Securities丨The industry is booming, and the pharmaceutical sector has long-term investment value_Shenzhen Hotline

Since May, many places in China have successively implemented the results of centralized insulin collection. Listed companies have accelerated the pace of new product development and approval.

Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains

The concept of hepatitis fluctuates and strengthens, and the General Administration of Customs strictly prevents the introduction of acute severe hepatitis in children of unknown cause.

The concept of hepatitis fluctuates and strengthens, and the General Administration of Customs strictly prevents the introduction of acute severe hepatitis in children of unknown cause-CFi.CN Zhongcai Network

The concept of hepatitis fluctuates and strengthens, and the General Administration of Customs is strictly preventing the introduction of acute severe hepatitis in children of unknown cause – yqqlm

5 shares were significantly increased by important shareholders (with shares) Securities Journal

5 shares were significantly increased by important shareholders (with shares) _ Oriental Fortune Net

One single top one year! Porton shares catch Pfizer's "ride", the production capacity is tight and the construction of factories is accelerated_Oriental Fortune Network

One single top one year! Porton shares ride on Pfizer's "hitchhiker" to accelerate the construction of factories due to tight production capacity jqknews

One single top one year! Porton shares catch Pfizer's "ride", and the production capacity is tight to accelerate the construction of factories

Red Star Meiling was vetoed and angry with supervision

Lepu Medical (300003.SZ) plans to launch the 2022 restricted stock incentive plan grant price of 11.01 yuan / share

Want to see more data? Registered subscribers can see all the data.